Aquestive Therapeutics, Inc.

Healthcare

NASDAQ:AQST · NASDAQ Global Market

Market Cap $439.93M Beta 1.45 P/E (TTM) -8.3

$4.71 +5.08%

+$0.23 today

52W Low $2.93High $7.55

Vol 2.97M · Avg 1.51M

EPS (TTM) -$0.56Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+43.16%

Period High

$7.49

Period Low

$2.95

Latest

$4.71

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Erasca, Inc.

NASDAQ:ERAS

$4.26B

MoonLake Immunotherapeutics

NASDAQ:MLTX

$1.42B

Esperion Therapeutics, Inc.

NASDAQ:ESPR

$656.99M

Arvinas, Inc.

NASDAQ:ARVN

$487.78M

Emergent BioSolutions Inc.

NYSE:EBS

$410.19M

Orthofix Medical Inc.

NASDAQ:OFIX

$371.68M

SNDL Inc.

NASDAQ:SNDL

$368.32M

SIGA Technologies, Inc.

NASDAQ:SIGA

$307.90M

Anavex Life Sciences Corp.

NASDAQ:AVXL

$243.26M

DarioHealth Corp.

NASDAQ:DRIO

$50.92M

What is the latest AQST filing?

The latest filing shown is 4 dated Jun 16, 2026.

How many recent filings does AQST have?

Intrinsic Alpha currently shows 20 recent filings for AQST.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.